PHAC Infobulletin on VITT for Healthcare Providers

Update on vaccine-induced immune thrombotic throm

There have been a number of developments globally in recent weeks on the AstraZeneca COVID-19 vaccine, including concerns related to vaccine-induced immune thrombotic thrombocytopenia (VITT).

The Public Health Agency of Canada prepared a short information bulletin on AstraZeneca and VITT. The bulletin compiles statements and guidance documents on these topics from a number of federal and provincial sources.

Download the PHAC Information Bulletin